Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Breast cancer risk factors and their effects on survival: a Mendelian randomisation study

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Escala-Garcia, M, Morra, A, Canisius, S, Chang-Claude, J, Kar, S, Zheng, W, Bojesen, SE, Easton, D, Pharoah, PDP & Schmidt, MK 2020, 'Breast cancer risk factors and their effects on survival: a Mendelian randomisation study', BMC Medicine, vol. 18, no. 1, 327, pp. 327. https://doi.org/10.1186/s12916-020-01797-2

APA

Escala-Garcia, M., Morra, A., Canisius, S., Chang-Claude, J., Kar, S., Zheng, W., Bojesen, S. E., Easton, D., Pharoah, P. D. P., & Schmidt, M. K. (2020). Breast cancer risk factors and their effects on survival: a Mendelian randomisation study. BMC Medicine, 18(1), 327. [327]. https://doi.org/10.1186/s12916-020-01797-2

CBE

Escala-Garcia M, Morra A, Canisius S, Chang-Claude J, Kar S, Zheng W, Bojesen SE, Easton D, Pharoah PDP, Schmidt MK. 2020. Breast cancer risk factors and their effects on survival: a Mendelian randomisation study. BMC Medicine. 18(1):327. https://doi.org/10.1186/s12916-020-01797-2

MLA

Vancouver

Escala-Garcia M, Morra A, Canisius S, Chang-Claude J, Kar S, Zheng W et al. Breast cancer risk factors and their effects on survival: a Mendelian randomisation study. BMC Medicine. 2020 Nov 17;18(1):327. 327. https://doi.org/10.1186/s12916-020-01797-2

Author

Escala-Garcia, Maria ; Morra, Anna ; Canisius, Sander ; Chang-Claude, Jenny ; Kar, Siddhartha ; Zheng, Wei ; Bojesen, Stig E ; Easton, Doug ; Pharoah, Paul D P ; Schmidt, Marjanka K. / Breast cancer risk factors and their effects on survival : a Mendelian randomisation study. In: BMC Medicine. 2020 ; Vol. 18, No. 1. pp. 327.

Bibtex

@article{976f3d89eb994e9bbb6a16bd17d7f698,
title = "Breast cancer risk factors and their effects on survival: a Mendelian randomisation study",
abstract = "BACKGROUND: Observational studies have investigated the association of risk factors with breast cancer prognosis. However, the results have been conflicting and it has been challenging to establish causality due to potential residual confounding. Using a Mendelian randomisation (MR) approach, we aimed to examine the potential causal association between breast cancer-specific survival and nine established risk factors for breast cancer: alcohol consumption, body mass index, height, physical activity, mammographic density, age at menarche or menopause, smoking, and type 2 diabetes mellitus (T2DM).METHODS: We conducted a two-sample MR analysis on data from the Breast Cancer Association Consortium (BCAC) and risk factor summary estimates from the GWAS Catalog. The BCAC data included 86,627 female patients of European ancestry with 7054 breast cancer-specific deaths during 15 years of follow-up. Of these, 59,378 were estrogen receptor (ER)-positive and 13,692 were ER-negative breast cancer patients. For the significant association, we used sensitivity analyses and a multivariable MR model. All risk factor associations were also examined in a model adjusted by other prognostic factors.RESULTS: Increased genetic liability to T2DM was significantly associated with worse breast cancer-specific survival (hazard ratio [HR] = 1.10, 95% confidence interval [CI] = 1.03-1.17, P value [P] = 0.003). There were no significant associations after multiple testing correction for any of the risk factors in the ER-status subtypes. For the reported significant association with T2DM, the sensitivity analyses did not show evidence for violation of the MR assumptions nor that the association was due to increased BMI. The association remained significant when adjusting by other prognostic factors.CONCLUSIONS: This extensive MR analysis suggests that T2DM may be causally associated with worse breast cancer-specific survival and therefore that treating T2DM may improve prognosis.",
keywords = "Breast cancer risk factors, Breast cancer survival, GWAS Catalog, Lifestyle, Mendelian randomisation",
author = "Maria Escala-Garcia and Anna Morra and Sander Canisius and Jenny Chang-Claude and Siddhartha Kar and Wei Zheng and Bojesen, {Stig E} and Doug Easton and Pharoah, {Paul D P} and Schmidt, {Marjanka K}",
year = "2020",
month = nov,
day = "17",
doi = "10.1186/s12916-020-01797-2",
language = "English",
volume = "18",
pages = "327",
journal = "BMC Medicine",
issn = "1741-7015",
publisher = "BioMed Central Ltd",
number = "1",

}

RIS

TY - JOUR

T1 - Breast cancer risk factors and their effects on survival

T2 - a Mendelian randomisation study

AU - Escala-Garcia, Maria

AU - Morra, Anna

AU - Canisius, Sander

AU - Chang-Claude, Jenny

AU - Kar, Siddhartha

AU - Zheng, Wei

AU - Bojesen, Stig E

AU - Easton, Doug

AU - Pharoah, Paul D P

AU - Schmidt, Marjanka K

PY - 2020/11/17

Y1 - 2020/11/17

N2 - BACKGROUND: Observational studies have investigated the association of risk factors with breast cancer prognosis. However, the results have been conflicting and it has been challenging to establish causality due to potential residual confounding. Using a Mendelian randomisation (MR) approach, we aimed to examine the potential causal association between breast cancer-specific survival and nine established risk factors for breast cancer: alcohol consumption, body mass index, height, physical activity, mammographic density, age at menarche or menopause, smoking, and type 2 diabetes mellitus (T2DM).METHODS: We conducted a two-sample MR analysis on data from the Breast Cancer Association Consortium (BCAC) and risk factor summary estimates from the GWAS Catalog. The BCAC data included 86,627 female patients of European ancestry with 7054 breast cancer-specific deaths during 15 years of follow-up. Of these, 59,378 were estrogen receptor (ER)-positive and 13,692 were ER-negative breast cancer patients. For the significant association, we used sensitivity analyses and a multivariable MR model. All risk factor associations were also examined in a model adjusted by other prognostic factors.RESULTS: Increased genetic liability to T2DM was significantly associated with worse breast cancer-specific survival (hazard ratio [HR] = 1.10, 95% confidence interval [CI] = 1.03-1.17, P value [P] = 0.003). There were no significant associations after multiple testing correction for any of the risk factors in the ER-status subtypes. For the reported significant association with T2DM, the sensitivity analyses did not show evidence for violation of the MR assumptions nor that the association was due to increased BMI. The association remained significant when adjusting by other prognostic factors.CONCLUSIONS: This extensive MR analysis suggests that T2DM may be causally associated with worse breast cancer-specific survival and therefore that treating T2DM may improve prognosis.

AB - BACKGROUND: Observational studies have investigated the association of risk factors with breast cancer prognosis. However, the results have been conflicting and it has been challenging to establish causality due to potential residual confounding. Using a Mendelian randomisation (MR) approach, we aimed to examine the potential causal association between breast cancer-specific survival and nine established risk factors for breast cancer: alcohol consumption, body mass index, height, physical activity, mammographic density, age at menarche or menopause, smoking, and type 2 diabetes mellitus (T2DM).METHODS: We conducted a two-sample MR analysis on data from the Breast Cancer Association Consortium (BCAC) and risk factor summary estimates from the GWAS Catalog. The BCAC data included 86,627 female patients of European ancestry with 7054 breast cancer-specific deaths during 15 years of follow-up. Of these, 59,378 were estrogen receptor (ER)-positive and 13,692 were ER-negative breast cancer patients. For the significant association, we used sensitivity analyses and a multivariable MR model. All risk factor associations were also examined in a model adjusted by other prognostic factors.RESULTS: Increased genetic liability to T2DM was significantly associated with worse breast cancer-specific survival (hazard ratio [HR] = 1.10, 95% confidence interval [CI] = 1.03-1.17, P value [P] = 0.003). There were no significant associations after multiple testing correction for any of the risk factors in the ER-status subtypes. For the reported significant association with T2DM, the sensitivity analyses did not show evidence for violation of the MR assumptions nor that the association was due to increased BMI. The association remained significant when adjusting by other prognostic factors.CONCLUSIONS: This extensive MR analysis suggests that T2DM may be causally associated with worse breast cancer-specific survival and therefore that treating T2DM may improve prognosis.

KW - Breast cancer risk factors

KW - Breast cancer survival

KW - GWAS Catalog

KW - Lifestyle

KW - Mendelian randomisation

UR - http://www.scopus.com/inward/record.url?scp=85096065563&partnerID=8YFLogxK

U2 - 10.1186/s12916-020-01797-2

DO - 10.1186/s12916-020-01797-2

M3 - Journal article

C2 - 33198768

VL - 18

SP - 327

JO - BMC Medicine

JF - BMC Medicine

SN - 1741-7015

IS - 1

M1 - 327

ER -

ID: 61973801